tod

2021

Publications

• Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infections

Posters

• Coût des antibiothérapies hors AMM dans les infections ostéo-articulaires : Etude prospective observationnelle sur 6 ans dans un Centre de Référence pour la prise en charge des IOA complexes (CRIOAc)
• Results of a collaboration between a CRPV and an infectious disease care service

2019

Posters

• Tolerance and microbiological efficacy cefepim or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of PJI
• Comparison of tolerance and microbiological efficacy of cefepim and piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study

2018

Thèses

• Augmentation du risque d’insuffisance rénale aigue lors de l’utilisation concomitante de vancomycine et piperacilline tazobactam : analyse de la base nationale de pharmacovigilance

Publications

• Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy

2017

Posters

• Cost of off-label antibiotic therapy in bone and joint infection (BJI) : prospective 2-year study in a complex BJI reference center

Publications

• Mechanisms of drug-drug interaction between rifampicin and fusidic acid

2015

Formation continue et webinaires

• PK/PD : dans l’os aussi !

2014

Publications

• Antimicrobial-related Severe Adverse Events During Treatment of Bone and Joint Infection Due to Methicillin-Susceptible Staphylococcus Aureus